There is a need for better and safer anti-inflammatory treatments

AimVion will be a leading company in the field of anti-inflammation drug discovery and development

Mission

Our mission is to discover new drugs and develop better treatments for autoimmune and inflammatory conditions.

Technology

Aimvion’s anti-inflammatory peptides designed based on proteins involved in the human immune system.

People

A strong team of scientists, administrators and entrepreneurs have made AimVion a reality.

Company

AimVion is a privately held research and development company focused on peptide based drug development.

IPR

Proprietary intellectual property for a new class of anti-inflammatory peptides.

Investment

AimVion is preparing for its series A investment round.

Partnering

We are continuously looking for opportunities to collaborate with scientists and industry partners.

Read more about vision and goals

Learn more